SRRK240719C30000
- 1.00
- 0.000.00%
Scholar Rock Newsroom
Express News | Scholar Rock to Host Conference Call to Discuss Second Quarter 2024 Financial Results and Provide Business Update on August 8, 2024
Full-Life Technologies Announces the Appointment of Edward (Ted) Myles to Its Board of Directors
Scholar Rock Holding Corporation (SRRK): The Most Shorted Stock Loved by Analysts?
H.C. Wainwright Maintains Scholar Rock(SRRK.US) With Buy Rating, Maintains Target Price $30
Scholar Rock Provides Preclinical Data for Its Investigational Obesity Candidate
Express News | Scholar Rock Has Dosed The First Participants In The Phase 2 EMBRAZE Proof-of-concept Trial Of Apitegromab To Preserve Lean Muscle Mass In Individuals Living With Obesity And On Background Therapy Of A GLP-1 Receptor Agonist
Express News | Scholar Rock Holding Corp: First Participants Were Dosed in Phase 2 Embraze Proof-of-Concept Trial
Express News | Scholar Rock Announces New Srk-439 Preclinical Data Showing Significant Lean Mass Preservation and Attenuation of Fat Mass Rebound Following GLP-1 Receptor Agonist Withdrawal
Have Insiders Sold Scholar Rock Holding Shares Recently?
Scholar Rock Reports New Employee Inducement Grants Under Nasdaq Listing Rule 5635(c)(4)
Scholar Rock Holding Is Maintained at Outperform by BMO Capital
BMO Capital Maintains Scholar Rock(SRRK.US) With Buy Rating, Raises Target Price to $31
Express News | Scholar Rock Holding Corp : BMO Raises Target Price to $31 From $29
BMO Capital Maintains Scholar Rock(SRRK.US) With Buy Rating, Maintains Target Price $29
Truist Financial Maintains Scholar Rock(SRRK.US) With Buy Rating
Scholar Rock Reports 'Encouraging' Phase 1 Trial Results in Advanced Solid Tumors
12 Health Care Stocks Moving In Monday's After-Market Session
Express News | Scholar Rock Holding Corp - Promising Objective Response Rates (Orr) Were Observed in Multiple Tumor Types in Anti-Pd-(L)1 Resistant Patients
Express News | Scholar Rock Holding Corp - Srk-181 Combination With Pembrolizumab Was Generally Well Tolerated
Express News | Scholar Rock Presents New Data From Srk-181 Phase 1 Dragon Trial at Asco 2024 Annual Meeting